Evidence mapPaperPMID 31758212Full record

ArticleDiabetologia2020

Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals.

Laura J McCreight, Andrea Mari, Lucy Coppin, Nicola Jackson, A Margot Umpleby, Ewan R Pearson

Full text readLetter
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Metformin acts in the gut and induces gut-liver crosstalk.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Review
  12. Let-7 underlies metformin-induced inhibition of hepatic glucose production.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Metabolomic Approaches to Investigate the Effect of Metformin: An Overview.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura J McCreightDivision of Population Health and Genomics, University of Dundee, Ninewells Hospital, Dundee, DD19SY, UK.
Andrea MariInstitute of Neuroscience, National Research Council, Padova, Italy.
Lucy CoppinFaculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Nicola JacksonFaculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
A Margot UmplebyFaculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Ewan R PearsonDivision of Population Health and Genomics, University of Dundee, Ninewells Hospital, Dundee, DD19SY, UK. e.z.pearson@dundee.ac.uk.ORCID http://orcid.org/0000-0001-9237-8585

Funding

Wellcome Trust 102820/Z/13/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultBlood GlucoseDiabetes Mellitus, Type 2FastingFemaleHumansMaleMetforminYoung AdultBlood GlucoseMetforminEndogenous glucose productionGlucose clearanceMetforminMixed-meal testStable isotopes

Identifiers

PMID31758212
PMCPMC6946719

What Socratic holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.